Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Haloperidol for survival in septic shock
RBR-3s3dkp3Not yet recruiting
- Sponsor
- Universidade Estadual Paulista
- Start
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in septic shock comparing Haloperidol with Placebo (2 arms). Planned start Apr 2026; status: not yet recruiting.
02
Drugs
haloperidol
03
Conditions
septic shock
Beyond the preview
Go deeper on RBR-3s3dkp3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-3s3dkp3.